• Eclipta–Barley Extract Delays Precocious Puberty in Danazol

  2026-07-15

  The referenced study demonstrates that an herbal extract complex of Eclipta prostrata and Hordeum vulgare (EHEC) delays the onset of precocious puberty in rat models induced by Danazol or high-fat diet. By modulating the hypothalamic–pituitary–gonadal axis, EHEC provides a novel natural strategy for managing early puberty, suggesting new avenues for endocrine research.

• Oteseconazole (VT-1161): Reliable Antifungal for Candida Ass

  2026-07-15

  This article guides laboratory scientists through scenario-driven questions on using Oteseconazole (VT-1161) (SKU BA1665) for sensitive, reproducible Candida assays. We address assay optimization, data interpretation, and vendor reliability, referencing current literature and product specifications to help researchers achieve robust results with this advanced antifungal compound.

• Gastrin I (human): Precision Modeling of Gastric Acid Secret

  2026-07-14

  Explore the advanced use of human Gastrin I peptide in dissecting gastric acid secretion mechanisms with unprecedented precision. This article offers new technical depth on leveraging Gastrin I for in vitro modeling, integrating recent organoid innovations and unique assay optimization strategies.

• Cyclosporin A: Dissecting Cyclophilin Dependency in Immunosu

  2026-07-14

  Explore the cyclophilin-specific mechanisms of Cyclosporin A and their impact on immunosuppression research. This in-depth analysis offers new insights beyond standard T-cell or mitochondrial workflows, guiding advanced assay design.

• Scenario-Driven Solutions with Angiotensin 1/2 (2-7) Peptide

  2026-07-13

  This article provides an evidence-based, scenario-driven exploration of how Angiotensin 1/2 (2-7) (SKU A1050) addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assay workflows. Emphasizing protocol precision, reproducibility, and literature-backed performance, it guides biomedical researchers in leveraging this high-purity vasoconstrictor peptide for advanced renin-angiotensin signaling studies.

• Applied Workflows and Troubleshooting with Resiniferatoxin (

  2026-07-13

  Resiniferatoxin (RTX) redefines pain and neuroinflammation research by enabling ultra-selective, durable TRPV1 inactivation. This guide demystifies advanced protocols, troubleshooting, and translational insights, empowering scientists to harness RTX's breakthrough potential in preclinical and clinical workflows.

• Reactive Oxygen Species Assay Kit: Precision DHE Probe Workf

  2026-07-12

  Unlock high-sensitivity detection of intracellular superoxide with the Reactive Oxygen Species Assay Kit (DHE). This guide integrates the latest mechanistic insights and workflow optimizations for robust oxidative stress and apoptosis research.

• Scenario-Driven Best Practices for Tropifexor (LJN452) in FX

  2026-07-10

  This article delivers scenario-driven guidance for leveraging Tropifexor (LJN452) (SKU BA3602) in cell-based and metabolic assays. Drawing on practical laboratory workflows and peer-reviewed data, it demonstrates how this potent FXR agonist addresses reproducibility, assay sensitivity, and vendor selection for intestinal epithelial and metabolic disease research.

• gamma-Glu-Cys (γ-Glu-Cys): Technical Guidance for Lab Workfl

  2026-07-09

  gamma-Glu-Cys (γ-Glu-Cys) is a high-purity substrate required for precise glutathione metabolism research, thiol-reactive peptide synthesis, and plant stress adaptation studies. It is not suitable for in vivo, diagnostic, or medical applications, and researchers must follow strict handling and storage protocols for reproducibility.

• Capecitabine in 3D Tumor Models: Innovations in Preclinical

  2026-07-09

  Explore Capecitabine's role as a fluoropyrimidine prodrug in next-generation 3D tumor models. This article uncovers how integrating N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine with advanced assembloid systems redefines preclinical oncology research.

• Capsazepine Targets MCL1 to Reverse Tamoxifen Resistance in

  2026-07-08

  This study identifies capsazepine as a novel MCL1 inhibitor capable of overcoming tamoxifen resistance in estrogen receptor–positive breast cancer. Through integrated computational and experimental approaches, the authors demonstrate that capsazepine directly binds and destabilizes MCL1, restoring apoptotic sensitivity and suggesting new therapeutic strategies for endocrine-resistant breast cancer.

• Resiniferatoxin (RTX): Precision TRPV1 Modulation for Transl

  2026-07-08

  Explore the mechanistic foundation and translational strategies for leveraging Resiniferatoxin (RTX) in pain and immune modulation research. This article contextualizes RTX’s ultra-selective TRPV1 targeting, highlights critical immune considerations from recent literature, and offers actionable guidance for experimental design and protocol optimization.

• Redefining Gastric Acid Research with Human Gastrin I Peptid

  2026-07-07

  This thought-leadership article explores how human Gastrin I peptide enables next-generation gastric acid secretion pathway research. Integrating mechanistic insights, stem cell-derived organoid advances, and strategic guidance for translational researchers, it positions APExBIO’s Gastrin I (human) as the gold standard for experimental rigor and translational relevance.

• Lopinavir Identified as Low-Micromolar MERS-CoV Inhibitor

  2026-07-07

  de Wilde et al. systematically screened FDA-approved compounds and identified Lopinavir (ABT-378) as one of four small molecules that inhibit MERS-CoV replication in cell culture at low micromolar concentrations. This finding advances rapid drug repurposing strategies for emerging coronaviruses and underscores the translational relevance of HIV protease inhibitors in antiviral research.

• Localized Muscle BDNF Release Directs Early Neuromuscular Sy

  2026-07-06

  This study reveals how spatially restricted, activity-dependent release of muscle-derived BDNF governs the initial assembly of acetylcholine receptor clusters at developing neuromuscular junctions. The findings provide new mechanistic insight into the intracellular trafficking and proteolytic processing of BDNF in muscle cells, with implications for understanding synaptic development and its calcium dependence.

14820 records 1/988 page Next 12345 下5页 Last page